VRTX
VRTX
US92532F1003
Vertex Pharmaceuticals Incorpor
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
129.2B EUR
125.85B EUR
113.49B EUR
115.15B EUR
Enterprise Value
121.68B EUR
121.68B EUR
109.99B EUR
112.1B EUR
Valuation Multiples
Trailing P/E
29.71x
28.57x
26.16x
34.82x
Forward P/E
25.37x
--
--
--
Price to Sales
10.26x
10x
9.29x
12.47x
Price to Book
6.38x
6.22x
5.86x
6.17x
EV/Revenue
9.67x
9.67x
9x
12.14x
EV/EBITDA
23.86x
23.11x
21.45x
28.51x
Price to FCF (P/FCF)
49.17x
33.15x
30.59x
47.67x
EV/FCF
46.3x
32.05x
29.64x
46.4x
FCF Yield
2.03%
3.02%
3.27%
2.1%
ende